Unknown

Dataset Information

0

Risk of hip/femur fractures during the initiation period of ?-adrenoceptor blocker therapy among elderly males: a self-controlled case series study.


ABSTRACT:

Aims

This study aimed to evaluate the risk of hip/femur fractures during the initiation period of ?-adrenoceptor blocker therapy using the National Health Insurance claims database, Taiwan, with a self-controlled case series design.

Methods

All male beneficiaries aged over 50?years as of 2007, who were incident users of ?-adrenoceptor blockers and also had a diagnosis of hip/femur fracture within the 2007-2009 study period were identified. The first day when the ?-adrenoceptor blocker was prescribed was set as the index date. We partitioned the initial 21 day period following the index date as the post-exposure risk period 1, days 22-60 after the index date as the post-exposure risk period 2, the 21 day period prior to the index date as the pre-exposure risk period 1 and days 22-60 prior to the index date as the pre-exposure risk period 2. The remainder of the study period was defined as the unexposed period. The incidence rate ratio (IRR) of hip/femur fractures within each risk period compared with the unexposed period was estimated using a conditional Poisson regression model.

Results

A total of 5875 men were included. Compared with the unexposed period, the IRR of hip/femur fractures was 1.36 (95% confidence interval 1.06, 1.74, P = 0.017) within the post-exposure risk period 1 for patients without concomitant prescriptions of anti-hypertensive agents.

Conclusions

Use of ?-adrenoceptor blockers was associated with a small but significant increase in the risk of hip/femur fractures during the early initiation period in patients without concomitant prescriptions of anti-hypertensive agents.

SUBMITTER: Lai CL 

PROVIDER: S-EPMC4631193 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study.

Lai Chao-Lun CL   Kuo Raymond Nien-Chen RN   Chen Ho-Min HM   Chen Ming-Fong MF   Chan Kinwei Arnold KA   Lai Mei-Shu MS  

British journal of clinical pharmacology 20150922 5


<h4>Aims</h4>This study aimed to evaluate the risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy using the National Health Insurance claims database, Taiwan, with a self-controlled case series design.<h4>Methods</h4>All male beneficiaries aged over 50 years as of 2007, who were incident users of α-adrenoceptor blockers and also had a diagnosis of hip/femur fracture within the 2007-2009 study period were identified. The first day when the α-adrenoceptor blo  ...[more]

Similar Datasets

| S-EPMC7251496 | biostudies-literature
| S-EPMC8069667 | biostudies-literature
| S-EPMC6630011 | biostudies-literature
| S-EPMC5531925 | biostudies-other
| S-EPMC9843827 | biostudies-literature
| S-EPMC1397761 | biostudies-literature
| S-EPMC6940317 | biostudies-literature
| S-EPMC6029464 | biostudies-literature
| S-EPMC4984486 | biostudies-literature
| S-EPMC8506166 | biostudies-literature